Watchlist Price Alert

Aldeyra Therapeutics Inc. (ALDX)

NASDAQ: ALDX · Real-Time Price · USD

3.08

0.06 (1.99%)

At close: Jun 17, 2025, 10:14 AM

Aldeyra Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-55.85M	-37.54M	-62.02M	-57.78M	-37.55M	-60.83M	-38.89M	-22.34M	-18.7M
Depreciation & Amortization	249.62K	262.78K	258.71K	264.18K	56.22K	96.31K	71K	37.85K	35.79K
Stock-Based Compensation	7.97M	5.75M	8.29M	7.11M	7.08M	8.08M	4.14M	2.71M	2.76M
Other Working Capital	7.07M	-343.25K	-2.56M	6.8M	-8.4M	5.59M	2.95M	-510.07K	1.04M
Other Non-Cash Items	-1.49M	339.65K	283.9K	409.47K	2.23M	6.23M	59.32K	20.34K	27.31K
Deferred Income Tax	n/a	n/a	n/a	n/a	-479.26K	-1.31M	-237.54K	129.25K	266.11K
Change in Working Capital	5.91M	861.18K	-3.44M	7.44M	-8.83M	2.74M	5M	215.45K	462.97K
Operating Cash Flow	-43.21M	-30.33M	-56.64M	-42.56M	-37.49M	-44.98M	-29.86M	-19.22M	-15.15M
Capital Expenditures	n/a	n/a	-16.32K	-7.81K	n/a	-9.53K	-262.97K	-24.76K	-11.81K
Cash Acquisitions	n/a	n/a	16.32K	n/a	n/a	609.46K	262.97B	24.76B	11.81K
Purchase of Investments	-96.92M	n/a	-92.94M	n/a	-5.78M	-57.77M	-59.73M	-35.1M	-16.05M
Sales Maturities Of Investments	52M	30M	63M	n/a	34.8M	75.64M	36.66M	24.92M	15.84M
Other Investing Acitivies	n/a	n/a	-16.32K	-7.81B	29.02K	18.49K	-262.97B	-24.76B	-11.81K
Investing Cash Flow	-44.92M	30M	-29.95M	-7.81K	29.02M	18.48M	-23.34M	-10.2M	-225.23K
Debt Repayment	-292.5K	-1.04M	n/a	n/a	n/a	14.45M	n/a	n/a	n/a
Common Stock Repurchased	n/a	-532.95K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	121.08K	-532.95K	1.22M	4.68M	1.19M	1.23M	-1.4M	-165.93K	n/a
Financial Cash Flow	-171.42K	-1.27M	1.22M	194.5M	41.9M	23.58M	80.53M	37.43M	12.74M
Net Cash Flow	-88.3M	-1.6M	-85.37M	151.93M	33.43M	-2.93M	27.33M	8.01M	-2.63M
Free Cash Flow	-43.21M	-30.33M	-56.65M	-42.56M	-37.49M	-44.99M	-30.12M	-19.25M	-15.16M